Melio provides a quick and comprehensive blood test that detects all prevalent infections.
Melio has raised $3.5M in total funding. The most recent round was Grant. The last funding was announced in January 2025.
Melio's investors include SOSV, CARB-X, SOSV SF & NY (Fka IndieBio), Lexi Ventures, Vye Ventures.
Melio is headquartered in Santa Clara, United States.
Melio provides a quick and comprehensive blood test that detects all prevalent infections.
Melio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Melio — Funding & Investors." VCBacked, January 14, 2025, https://www.vcbacked.co/company/melio-santa-clara. Accessed October 21, 2026.
VCBacked. (2025). Melio — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/melio-santa-clara
{{cite web |title=Melio — Funding & Investors |url=https://www.vcbacked.co/company/melio-santa-clara |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated